XML 87 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Segment and Geographic Information (Tables)

12 Months Ended

Apr. 26, 2024

Segment Reporting [Abstract]

Schedule of Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated

Segment Operating Profit

			Fiscal Year
(in millions)			2024						2023						2022
Cardiovascular			$	4,474					$	4,522					$	4,596
Neuroscience			3,940						3,712						3,858
Medical Surgical			3,170						3,048						3,698
Diabetes			394						383						588
Reportable segment operating profit			11,979						11,664						12,740
Other operating segment (1)			10						(89)						(31)
Corporate			(1,784)						(1,763)						(1,724)
Interest expense			(719)						(636)						(553)
Other non-operating income, net			412						515						318
Amortization of intangible assets			(1,693)						(1,698)						(1,733)
Stock-based compensation			(393)						(355)						(358)
Centralized distribution costs			(1,609)						(1,558)						(1,741)
Currency (2)			68						465						70
Restructuring and associated costs			(389)						(647)						(335)
Acquisition and divestiture-related items			(777)						(345)						(838)
Certain litigation charges, net			(149)						30						(95)
IPR&D charges			—						—						(101)
Medical device regulations			(119)						(150)						(102)
Commitments to the Medtronic Foundation and Medtronic LABS			—						(70)						—
Income before income taxes			$	4,837					$	5,364					$	5,517

(1) Includes the historical operations and ongoing transition agreements from businesses the Company has exited or divested, which primarily includes the Company's ventilator product line and the Renal Care Solutions business.

(2) Includes the net impact of remeasurement and the Company's hedging programs recorded in other operating expense (income), net.

Schedule of Reconciliation of Assets and Depreciation Expense from Segments to Consolidated

Total Assets and Depreciation Expense

			Total Assets												Depreciation Expense
(in millions)			April 26, 2024						April 28, 2023						2024						2023						2022
Cardiovascular			$	16,128					$	16,036					$	199					$	209					$	210
Neuroscience			18,270						18,346						252						267						265
Medical Surgical			33,586						34,926						194						203						186
Diabetes			3,996						3,930						94						80						67
Total reportable segments			71,980						73,238						739						759						728
Other operating segment (1)			547						1,337						—						2						18
Corporate			17,455						16,373						215						238						228
Total			$	89,981					$	90,948					$	954					$	999					$	974

(1) Includes the historical operations and ongoing transition agreements from businesses the Company has exited or divested, which primarily includes the Company's ventilator product line and the Renal Care Solutions business.

Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographical Region

The following table presents net sales for fiscal years 2024, 2023, and 2022, and property, plant, and equipment, net at April 26, 2024 and April 28, 2023 for the Company's country of domicile, countries with significant concentrations, and all other countries:

			Net sales																		Property, plant, and equipment, net
(in millions)			2024						2023						2022						April 26, 2024						April 28, 2023
Ireland			$	113					$	98					$	101					$	252					$	184
United States			16,562						16,373						16,135						4,593						4,083
Rest of world			15,689						14,756						15,450						1,286						1,302
Total other countries, excluding Ireland			32,251						31,129						31,585						5,879						5,385
Total			$	32,364					$	31,227					$	31,686					$	6,131					$	5,569

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration